The objective of this study was to determine the distribution of cyclooxygenase-2 (COX-2) in eutopic and ectopic endometria in endometriosis and adenomyosis. The subjects were 35 patients with endometriosis diagnosed by laparoscopy, 33 patients with histologically confirmed adenomyosis and 50 female controls with normal fecundity. Expression of COX-2 was immunohistochemically investigated in tissues from eutopic endometrium and myometrium and ectopic endometrium of the wall of ovarian chocolate cysts using polyclonal antibody. Surface epithelial cells, endometrial glandular epithelial cells or stromal cells were assessed. Cells were semi-quantitatively assessed on a scale of 1 to 5 using a nomogram created from positive cell count and the degree of staining. COX-2 expression in surface and glandular epithelia of the control group varied markedly during the menstrual cycle. It was lowest in the early proliferative phase and gradually increased thereafter. It remained high throughout the secretory phase. However, in patients with endometriosis, expression of COX-2 in glandular epithelium was higher than that in the control group, though it varied throughout the menstrual cycle. On the other hand, there was no variation in expression of COX-2 in the adenomyosis group during the menstrual cycle, and it was lower than that in the endometriosis group in all phases. Pronounced COX-2 expression was observed in glandular cells from ectopic endometrial tissue of ovarian chocolate cyst walls in all cases regardless of the menstrual phase. In summary, increased COX-2 expression in eutopic and ectopic endometria was believed to be strongly correlated with pathological abnormalities in these disorders.
Introduction
intimately involved in reproductive functions. It has been proven that COX-2 knock-out mice were infertile, the corpus Cyclooxygenase-2 (COX-2) has prostaglandin (PG) hydroperluteum was missing and the uterus was small (Dinchuk oxidase activity to synthesize PGH 2 from PGG 2 . COX-2 et al., 1995) . exists in two isoforms, COX-1 and COX-2. The human It is known that human endometrium produces PGE 2 and COX-1 gene is localized on chromosome 9 and the COX-2 PGF 2α (Smith and Kelly, 1988) . It has been reported (Jones gene is localized on chromosome 1 (Hla and Neilson, 1992; that COX-2 is distributed in endometrial Appleby et al., 1994) . They are governed by completely glandular epithelia and vascular endothelia and that it varies different genes, but their protein structures are very similar.
during the menstrual cycle. Other studies have also found COX-1 is constitutively present in almost all tissues. It acts that COX-2 is distributed in the human placenta (Wetzka to maintain cell homeostasis (Zweifel et al., 1995) . COX-2 et al., 1997) and decidual tissue (Ishihara et al., 1995) . A is almost never expressed under normal conditions. It is significant amount of prostaglandins are produced from the induced during inflammation and cell proliferation and endometrium and endometriotic tissues (Lumsden et al., differentiation. It is expressed in macrophages, fibroblasts, 1984) . It is interesting to note that low concentrations of vascular endothelial cells, neurons and chondrocytes as a arachidonic acid are only metabolized by COX-2 (Morita result of interleukin-1 (IL-1) (O'Banion et al., 1992 (O'Banion et al., ), human et al., 1995 . Accordingly, COX-2 expression may be chorionic gonadotrophin (Sirois and Richards, 1992) or abnormal in endometriosis, but there appear to be no reports serum (Xie et al., 1991) stimulation. COX-2 is not only of investigations of COX-2 kinetics in this disorder. induced by the site of inflammation, but also produced in Therefore, in this study, we investigated the expression of COX-2 in eutopic and ectopic endometria in endometriosis. colon cancer tissues (Sheng et al., 1998) . COX-2 is also Negative controls for immunostaining were prepared by substituting in the patients with adenomyosis, endometrial tissue was obtained the first antibody with non-immune rabbit serum IgG. In each run, a when it became available during any phase of the menstrual cycle.
Materials and methods
section of placenta with strong COX-2 staining was routinely included Ectopic endometrial tissues in ovarian chocolate cysts in endometriosis as a positive control. (n ϭ 10) or in the myometrium in adenomyosis (n ϭ 9) were studied in the identical patients at the same time. In the control and Evaluation of staining the endometriosis group, endometrial specimens were obtained by Ten non-overlapping fields of view were examined per biopsy in a curettage. The tissues were fixed in neutral-buffered 10% formalin systematic random sampling pattern (magnification ϫ400). Surface solution. The menstrual cycle of the patients was estimated by and glandular epithelia and stromal cells in eutopic and ectopic endometrial dating according to previously described criteria (Noyes endometria were evaluated for COX-2 staining. Staining was evaluated et al., 1950). Informed consent was obtained in each case, and using an evaluation nomogram as previously reported (Ota and approval for the study was granted by the Institutional Review Board.
Igarashi, 1993). Briefly, each section was graded according to the frequency of positive cells and intensity of staining in endometrium.
Reagents
The frequency was defined as 1ϩ, 2ϩ or 3ϩ when the number of The goat polyclonal antibody for human COX-2 (sc-1745) raised positive cells in the endometrium in each section was Ͻ10%, 10-against a peptide mapping at the carboxy terminus of COX-2 of 50% or Ͼ50% respectively. Intensity was defined as 3ϩ when staining human origin was obtained from Santa Cruz Biotechnology Inc.
of the cells was as strong as that observed in the positive controls, (Santa Cruz, CA, USA). The second antibody [rabbit anti-sheep as 1ϩ when staining was weakly positive but distinct from the immunoglobulins (Ig) HϩL horseradish peroxidase conjugate; 6155-negative controls, and as 2ϩ when the staining was between 1ϩ and 04] was obtained from Southern Biotechnology Associates Inc.
3ϩ. The sections were ranked from 1 to 5 according to the evaluation (Birmingham, AL, USA).
nomogram. Sampling and grading of each specimen were done by two different observers blinded as to the specimen source. Sections Staining were assigned a score by a first observer, and confirmed by a The endometrial tissue samples were cut into blocks (~1 cm 3 ). Serial second observer. 3 mm sections of tissue were cut, deparaffinized, and rehydrated through ethanol, as in routine histology. The sections were stained Statistical analyses using the indirect method. Before the staining, a microwave antigen
The results are expressed as the mean Ϯ SEM where applicable. retrieval technique was utilized, whereby the sections were heated in Statistical analysis was performed by the Kruskal-Wallis test. P Ͻ sodium citrate buffer (pH 6.0) for 5 min at high power (500 W), and 0.05 was considered to be statistically significant. this was repeated four times. First, the sections were incubated in 3% hydrogen peroxide in phosphate-buffered saline solution (PBS; Table I ). It was lowest in the early proliferative phase and they were incubated for 1 h at 37°C. After washing the sections with PBS, they were stained with 0.2 mg/ml 3,3Ј-diaminobenzidine (DAB) gradually increased thereafter. It remained high throughout the varied throughout the menstrual cycle, but the range of the variation was narrower than that in the control group. In the late proliferative phase, expression of COX-2 was significantly more pronounced than that in the control group. On the other hand, there was no variation in expression of COX-2 in the more pronounced than that in the control group. On the other hand, there was no variation in expression of COX-2 in the adenomyosis group during the menstrual cycle.
COX-2 expression in the glandular epithelium in the control adenomyosis group during the menstrual cycle, and COX-2 expression was lower than that in the endometriosis group in group showed a similar tendency to the shift in expression in the surface epithelium (Figure 2 , Table II ). In other words, it all phases. Expression of COX-2 in stromal cells in the control group was lowest in the early proliferative phase and gradually increased thereafter. It peaked at the early secretory phase, was weaker than that in the surface and glandular epithelia, and there was no variation during the menstrual cycle (Table and the same amount of expression was maintained up to the late secretory phase. In patients with endometriosis, however, III). In patients with endometriosis, unlike that in the surface and glandular epithelia, there was no variation during the there was a significant variation in COX-2 expression during the menstrual cycle, but, like the surface epithelium, the menstrual cycle, but COX-2 expression tended to be slightly higher than that in the control group. In patients with adenodifference in expression was reduced. In the mid-to late proliferative phases, expression of COX-2 was significantly myosis, there was no difference from the control group. COX-2 expression in ectopic endometrium were 2.2 Ϯ 0.1 and 1.1 Ϯ 0.2 respectively, approximately the same as that in the early to mid-proliferative phases in the Expression of COX-2 was observed in ectopic endometrial eutopic endometrium. tissue in all cases. Mean evaluation nomogram levels in glandular epithelium and stromal cells in ovarian chocolate
Histological findings cyst wall were 3.0 Ϯ 0.2 and 1.3 Ϯ 0.2 respectively. They were higher than that in the secretory phase of the control COX-2 formed a granular pattern or texture in the cytoplasm of glandular cells and cells were stained almost diffusely group. On the other hand, evaluation nomogram scores in glandular epithelium and stromal cells in adenomyosis tissue (Figure 3 ). Pronounced localization was not found in cell membranes. Polarity in the basal and apical sides was not Myometrial movement in patients with endometriosis was observed using ultrasonography (Leyendecker et al., 1996) particularly pronounced. No localization was seen in nuclei. Cytoplasm of interstitial cells was slightly positive.
and they found that hyperperistalsis and dysperistalsis are frequently observed in patients with endometriosis, and speculated that abnormal peristalsis may inhibit normal sperm Discussion transport in the uterus. Secondly, excessive prostaglandins may be impairing implantation of fertilized oocytes. The Expression of COX-2 varied with menstrual cycle. In a previous report , the expression of COX-2 implantation rate was said to have decreased significantly in an experimental endometriotic model using rabbits that were in endometrial glandular epithelium peaked at the menstrual phase, bottomed out in the ovulatory phase and gradually subsequently artificially inseminated (Hahn et al., 1986) . COX-2 expression was found in endometriotic tissues of began to increase again in the secretory phase. These results, however, differed slightly from theirs. In this study, it was the ovarian chocolate cyst wall in all cases, and expression of COX-2 in glandular epithelial cells was almost as pronounced low in the early proliferative phase and gradually increased thereafter. It peaked at the early secretory phase, and the same as that in the secretory phase in the eutopic endometrium. In fact, there have been many reports that large amounts of PGs amount of expression was maintained into the late secretory phase. Possible reasons for this difference include a variation are produced in ascites and endometrial tissues in endometriosis (Badawy et al., 1985; De Leon et al., 1986; Moon et al., 1981) . in controls (women with underlying disease versus healthy women with fecundity), parameters of assessing staining Over-expression of COX-2 in ectopic endometrial tissue, and prostaglandins that is produced as a result, may be involved (intensity only versus evaluation nomogram score), difference in the immunized animal for the first antibody (rabbit versus in the proliferation and differentiation of cells and malignant transformation. For example, it was reported that when COXgoat) and staining method. In addition, the volume of prostaglandins secreted from endometrium differs during the men-2 was over-expressed in epithelial cells of mouse small intestine, expression of adhesion molecules such as laminin strual cycle. The volume of PGE 2 and PGF 2α secreted from endometrial glandular epithelial cells was investigated in vitro increased, while apoptosis was suppressed (Tsujii and DeBois, 1995) . It has also been reported that the incidence of colon (Lumsden et al., 1984) . According to their findings, PGE 2 in the proliferative phase was 1.5 times that in the secretory cancer and the number and size of colorectal polyps decreased in people who took aspirin for an extended length of time phase, whereas PGF 2α was 3.4 times higher in the secretory phase. Consequently, increased expression of COX-2 in the (Giovannucci et al., 1995; Marcus, 1995) . It is said that apoptosis is reduced in the eutopic and ectopic endometria in secretory phase may contribute mainly to production of PGF 2α . This is the first study to look at the expression of COX-2 endometriosis compared with normal women (Dmowski et al., 1998; Imai et al., 2000) . Furthermore, apoptosis is further in eutopic and ectopic endometria in endometriosis. Expression of COX-2 in eutopic endometrium varied significantly during reduced in the ectopic endometrium compared with the eutopic endometrium (Gebel et al., 1998) . In fact, loss of heterozygosity the menstrual cycle. Expression was higher in the secretory phase than in the proliferative phase, but it was higher than was frequently observed on chromosomes in endometriotic tissue from ovarian chocolate cysts (Jiang et al., 1996) . It is that in the control throughout the menstrual cycle. Overexpression of COX-2 leads to increased production of prostaconcluded that COX-2 expression in endometriosis appears to be intimately involved in its pathology. Further investigations glandins. The mechanism of over-expression of COX-2 in eutopic endometrium in endometriosis is unclear. It has been into the involvement of COX-2 are required. indicated that an increased autoimmune response occurs in the endometrium in endometriosis. For instance, T cells and B cells are increased (Witz et al., 1994; Ota et al., 1996a) ,
